Chips Stocks Up, Inovio & Alcon Down: Upside Downside Movers in the A.M.

Upside

– $FOSL +23% (Q3 beat, gross margin surged and the FY sales and profit outlook was raised)

– $SATL +21% (record Q3 revenue, positive adjusted EBITDA and a post-quarter deal to sell three in-orbit satellites for about $37M)

– $RSKD +20% (Q3 revenue growth accelerated to 41% and revenue and adjusted EBITDA guidance was raised for a third time)

– $GEVO +18% (record Q3 results and higher 2026 EBITDA outlook, helped by carbon-credit sales)

– $CRWV +15% (Q3 revenue beat, the FY outlook was raised and backlog climbed to $132.5B)

– $NBIS +13%, $IREN +7.7%, $DELL +8.1%, $SMCI +5.8%, $VRT +6.2%, $ORCL +5.2% (AI-infrastructure names rise as CoreWeave’s beat-and-raise and customer-prepayment outlook ease demand and funding fears)

– $LITE +9.8%, $COHR +10.1%, $CRDO +8.1%, $AXTI +9.7%, $CIEN +7.9%, $AAOI +7.2% (AI-networking and optical suppliers rally on the stronger infrastructure-demand read-through)

– $STX +9.4%, $SNDK +8.8%, $WDC +8.7%, $MU +7.5% (AI storage and memory names rise on stronger infrastructure-demand expectations)

– $MRVL +9.3%, $TER +7.2%, $ALAB +8.2%, $ARM +6.6%, $INTC +6.5%, $AMD +5.6% (chip complex rallies as CoreWeave’s outlook reassures investors on AI compute demand)

– $NVDA +3.8%, $AVGO +4.5% (megacap chip names rebound as AI-infrastructure sentiment improves)

Downside

– $INVZ -17% (Q3 revenue missed badly and FY sales guidance came in far below expectations)

– $LWLG -16% (volume-production target slipped to 2028 as foundry and qualification delays extended timelines)

– $BV -13% (Q4 missed and FY2027 revenue guidance fell short)

– $GPRO -10% (delayed its Q3 filing and warned lender defaults could jeopardize the planned merger)

– $STIM -10% ($30M underwritten offering priced at $1.60 a share)

– $INO -9.7% (Q3 loss missed expectations despite the recent FDA approval, while fresh financing added stock supply)

– $VELO -8.1% (Q3 loss widened, the gross-margin target was withdrawn and the positive-EBITDA timeline moved to 2028)

– $ALC -4.2% (sales missed as implantables weakened, while market-growth and EPS-growth outlooks were narrowed)

• Category: Daily Diary
• Tag: AAOI, ALAB, ALC, AMD, ARM, AVGO, AXTI, BV, CIEN, COHR, CRDO, CRWV, DELL, FOSL, GEVO, GPRO, INO, INTC, INVZ, IREN, LITE, LWLG, MRVL, MU, NBIS, NVDA, ORCL, RSKD, SATL, SMCI, SNDK, STIM, STX, TER, VELO, VRT, WDC